In skin biopsies of patients with SS, MF, and subcutaneous panniculitis-like T-cell lymphoma (SPTL), a significant increase in CD39 expression was observed compared to patients with benign inflammatory disorders. This evidence concerns the gene ENTPD1 and T-cell non-Hodgkin lymphoma.